Eli Lilly to Buy AtaiBeckley for Initial $2.8 Billion
Eli Lilly has struck a deal to buy mental-health-focused AtaiBeckley for an initial $2.8 billion, continuing the drugmaker’s recent buying spree.
Connecting Global Economies
Flash News
UK court jails young hackers for massive London transport cyberattack
IRS CEO says Trump Accounts could reach all 70 million U.S. children
Josh Grisetti’s Family Speaks Out After His Death
What went right—and wrong—for the Minnesota Twins before the All-Star break
I Gave an AI Agent Access to My Passwords. Here’s What Happened.
4 Greek MPs charged over multimillion EU farm fraud scandal
IRS tax liens are increasing. What they can mean for your finances
Sam Neill’s Cause of Death Revealed After “Sudden” Death
Why the Atlanta Braves can’t afford to stand pat at the MLB trade deadline
Eli Lilly to Buy AtaiBeckley for Initial $2.8 Billion
Thursday, July 16, 2026